![](https://cdn.benzinga.com/files/images/story/2024/08/02/Cannabis-Pharma.png?width=1200&height=800&fit=crop)
Cannabis Pharmaceuticals: Company With Ties To Groundbreaking Medical Developments Pursues Cannabinoid-Based Medicines
Phytanix Bio, a preclinical stage pharmaceutical company, has released an updated investor deck. The presentation showcases a business strategy aimed at developing new cannabinoid-based pharmaceuticals. The company, which has ties to historical …